INTERNATIONAL PATENT: NEWAMSTERDAM PHARMA B.V. FILES APPLICATION FOR "IMPROVEMENT IN ATHEROSCLEROTIC PLAQUE CHARACTERISTICS WITH OBICETRAPIB"

GENEVA, July 14 -- NEWAMSTERDAM PHARMA B.V. (Gooimeer 2 351411 DC Naarden) filed a patent application (PCT/EP2024/088467) for "IMPROVEMENT IN ATHEROSCLEROTIC PLAQUE CHARACTERISTICS WITH OBICETRAPIB" on Dec 24, 2024. With publication no. WO/2025/146415, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KASTELEIN, Johannes Jacob Pieter (Gooimeer 2 351411 DC Naarden), DITMARSCH, Marc (Gooimeer 2 351411 DC Naarden), KLING, Douglas Fitzgerald (Gooimeer 2 351411 DC Naarden), CUI, Sheng (Gooimeer 2 351411 DC Naarden), ROTHELI, And...